Abstract:Breast cancer is a common malignancy with the highest mortality rate among women worldwide. Its incidence is on the rise year after year, accounting for more than one-tenth of new cancers worldwide. Increasing evidence suggests that forkhead box (FOX) transcription factors play an important role in the occurrence and development of breast cancer. However, little is known about the relationship between the expression, prognostic value, function, and immune infiltration of FOX transcription factors in tumor microenvironment. We used bioinformatics to investigate expression and function of FOX factor in breast cancer. Our results revealed the expression levels of FOXA1 and FOXM1 were significantly higher in breast cancer tissues than in normal tissues. The high expression of mRNA in FOXA1 (P < .05), FOXM1 (P < .01), and FOXP1 (P < .05) groups was related to tumor stage. Survival analysis results showed that increased FOXP1 mRNA levels were significantly associated with overall survival (OS), recurrence-free survival (RFS), and distant metastasis-free survival (DMFS) in all patients with breast cancer (P < .05). Patients with the FOXA1 high-expression group had better RFS and DMFS than the low-expression group (P < .05), while patients with FOXM1 high-expression group had worse RFS, OS, and DMFS than the low-expression group (P < .05). Meanwhile, mutation analysis showed that genetic alterations in FOX transcription factors were significantly associated with shorter OS and progression-free survival (P < .05), but not with disease-free survival (P = .710) in patients with breast cancer. FOXP1, FOXA1, and FOXM1 may be used as potential biomarkers to predict the prognosis of patients with breast cancer. Functional enrichment indicated that FOX was mainly involved in cell division, cell senescence, cell cycle, and prolactin signaling pathway. In patients with breast cancer, FOXC2 expression was negatively correlated with the infiltration of B cells and positively correlated with the infiltration of neutrophils and dendritic cells. However, FOXM1 was negatively correlated with the infiltration of CD8 + T cells and macrophages and positively correlated with the infiltration of neutrophils and dendritic cells. These findings provided novel insights into the screening of prognostic biomarkers of the FOX family in breast cancer and laid a foundation for further research on the immune infiltration of the FOX transcription factor family members in tumors.

Forkhead Box O4 Transcription Factor In Human Neoplasms: Cannot Afford To Lose The Novel Suppressor

FOXN Transcription Factors: Regulation and Significant Role in Cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

Research Progress in the Relationship Between FOXM1 and Neoplasm Metabolism

Role of Forkhead Box Class O proteins in cancer progression and metastasis

Mechanisms Controlling the Anti-Neoplastic Functions of FoxO Proteins.

An extensive analysis of the prognostic and immune role of FOXO1 in various types of cancer

FOXO4 Expression Associates with Glioblastoma Development and FOXO4 Expression Inhibits Cell Malignant Phenotypes in Vitro and in Vivo.

FOXO Signaling Pathways as Therapeutic Targets in Cancer

FOXO transcription factor family in cancer and metastasis

The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis

Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma

Dissecting multifunctional roles of forkhead box transcription factor D1 in cancers

Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC

The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer

FOXO1: Another Avenue for Treating Digestive Malignancy?

FOXO4 Inhibits the Migration and Metastasis of Colorectal Cancer by Regulating the APC2/β-Catenin Axis

The FOXO family of transcription factors: key molecular players in gastric cancer

TheCritical Role Ofdysregulatedfoxm1–plaursignaling in Human Colon Cancer Progression and Metastasis

FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer

FOXP4-AS1 May be a Potential Prognostic Biomarker in Human Cancers: A Meta-Analysis and Bioinformatics Analysis